Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Feibel, J. H.
	Articles by Schiffer, R. B.
	Search for Related Content



	PubMed Citation
	Articles by Feibel, J. H.
	Articles by Schiffer, R. B.

Am J Psychiatry 1981; 138:1115-1116
Copyright © 1981 by American Psychiatric Association

REGULAR ARTICLES

Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report

JH Feibel and RB Schiffer

The authors describe a patient with the neuroleptic malignant syndrome whose excessive catecholamine excretion indicates hyperactivity of the sympathoadrenomedullary component of the autonomic nervous system. Their finding provides a physiological basis for using catecholamine blocking agents to treat some patients with this syndrome.

This article has been cited by other articles:

J. R. Strawn, P. E. Keck Jr., and S. N. Caroff
Neuroleptic Malignant Syndrome
Am J Psychiatry, June 1, 2007; 164(6): 870 - 876.
[Full Text] [PDF]

M. Ueda, M. Hamamoto, H. Nagayama, K. Otsubo, C. Nito, T. Miyazaki, A. Terashi, and Y. Katayama
Susceptibility to neuroleptic malignant syndrome in Parkinson's disease
Neurology, March 1, 1999; 52(4): 777 - 777.
[Abstract] [Full Text] [PDF]

R. J. Gurrera
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Am J Psychiatry, February 1, 1999; 156(2): 169 - 180.
[Abstract] [Full Text]

Get information about faster international access.